Lluc Coll1, Mònica Parriego2, Beatriz Carrasco2, Ignacio Rodríguez2, Montserrat Boada2, Buenaventura Coroleu2, Nikolaos P Polyzos2, Francesca Vidal3, Anna Veiga4. 1. Reproductive Medicine Service, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Hospital Universitari Dexeus, Gran Via Carles III, 71-75, 08028, Barcelona, Spain. llucol@dexeus.com. 2. Reproductive Medicine Service, Department of Obstetrics, Gynaecology and Reproduction, Dexeus Mujer, Hospital Universitari Dexeus, Gran Via Carles III, 71-75, 08028, Barcelona, Spain. 3. Unitat de Biologia Cel·Lular, Facultat de Biociències, Universitat Autònoma de Barcelona, 08193, Bellaterra, Spain. 4. Barcelona Stem Cell Bank, IDIBELL Programme for Regenerative Medicine, Barcelona, L'Hospitalet de Llobregat, 08908, Spain.
Abstract
PURPOSE: To determine whether embryo mosaicism prevalence in preimplantation genetic testing for aneuploidy (PGT-A) cycles is associated with the trophectoderm biopsy technique used (a. number of laser pulses or b. the use of flicking or pulling) or the time to tubing. METHODS: Prospective observational study performed in a single IVF-PGT-A setting from May 2019 to May 2021. Trophectoderm biopsies were analysed by next-generation sequencing. Mosaicism was analysed in relation to the biopsy methodology (number of laser pulses and pulling vs flicking), time elapsed from biopsy to tubing (min), and time of sample cryostorage from tubing to amplification (days). As a secondary objective, the number of laser pulses and biopsy methodology were studied in relation to clinical outcomes of transferred euploid blastocysts. RESULTS: None of the analysed variables were associated to mosaicism prevalence. Multivariable regression analysis demonstrated that mosaicism prevalence was comparable either when > 3 laser pulses were used as compared to ≤ 3 (13.9% vs 13.8%, aOR = 0.8726 [0.60-1.28]) and pulling compared to flicking (13.1% vs 14.0%, aOR = 0.86 [0.60-1.23]). Moreover, neither the number of laser pulses during biopsy (> 3 vs ≤ 3) nor the technique used (pulling vs flicking) were associated with clinical pregnancy after the transfer of frozen-thawed euploid blastocysts (54.9% vs 55.2%, aOR = 1.05 [0.53-2.09]; 61.1% vs 52.9%, aOR = 1.11 [0.55-2.25], respectively). CONCLUSION: Our results suggest that, as long as the biopsy and tubing procedures are performed following standardized high quality procedures, no specific approach would increase the generation of artefactual mosaicism as a result of trophectoderm biopsy. Trophectoderm biopsies should be performed regardless of the methodology but always aiming on minimising blastocyst manipulation.
PURPOSE: To determine whether embryo mosaicism prevalence in preimplantation genetic testing for aneuploidy (PGT-A) cycles is associated with the trophectoderm biopsy technique used (a. number of laser pulses or b. the use of flicking or pulling) or the time to tubing. METHODS: Prospective observational study performed in a single IVF-PGT-A setting from May 2019 to May 2021. Trophectoderm biopsies were analysed by next-generation sequencing. Mosaicism was analysed in relation to the biopsy methodology (number of laser pulses and pulling vs flicking), time elapsed from biopsy to tubing (min), and time of sample cryostorage from tubing to amplification (days). As a secondary objective, the number of laser pulses and biopsy methodology were studied in relation to clinical outcomes of transferred euploid blastocysts. RESULTS: None of the analysed variables were associated to mosaicism prevalence. Multivariable regression analysis demonstrated that mosaicism prevalence was comparable either when > 3 laser pulses were used as compared to ≤ 3 (13.9% vs 13.8%, aOR = 0.8726 [0.60-1.28]) and pulling compared to flicking (13.1% vs 14.0%, aOR = 0.86 [0.60-1.23]). Moreover, neither the number of laser pulses during biopsy (> 3 vs ≤ 3) nor the technique used (pulling vs flicking) were associated with clinical pregnancy after the transfer of frozen-thawed euploid blastocysts (54.9% vs 55.2%, aOR = 1.05 [0.53-2.09]; 61.1% vs 52.9%, aOR = 1.11 [0.55-2.25], respectively). CONCLUSION: Our results suggest that, as long as the biopsy and tubing procedures are performed following standardized high quality procedures, no specific approach would increase the generation of artefactual mosaicism as a result of trophectoderm biopsy. Trophectoderm biopsies should be performed regardless of the methodology but always aiming on minimising blastocyst manipulation.
Authors: Buenaventura Coroleu; Pedro N Barri; Olga Carreras; Francisca Martínez; Anna Veiga; Juan Balasch Journal: Hum Reprod Date: 2002-11 Impact factor: 6.918
Authors: S Gaggiotti-Marre; F Martinez; L Coll; S Garcia; M Álvarez; M Parriego; P N Barri; N Polyzos; B Coroleu Journal: Gynecol Endocrinol Date: 2018-12-26 Impact factor: 2.260
Authors: Ashley W Tiegs; Xin Tao; Yiping Zhan; Christine Whitehead; Julia Kim; Brent Hanson; Emily Osman; Thomas J Kim; George Patounakis; Jacqueline Gutmann; Arthur Castelbaum; Emre Seli; Chaim Jalas; Richard T Scott Journal: Fertil Steril Date: 2020-08-28 Impact factor: 7.329
Authors: Tyl H Taylor; Susan A Gitlin; Jennifer L Patrick; Jack L Crain; J Michael Wilson; Darren K Griffin Journal: Hum Reprod Update Date: 2014-03-25 Impact factor: 15.610
Authors: Andrea R Victor; Darren K Griffin; Alan J Brake; Jack C Tyndall; Alex E Murphy; Laura T Lepkowsky; Archana Lal; Christo G Zouves; Frank L Barnes; Rajiv C McCoy; Manuel Viotti Journal: Hum Reprod Date: 2019-01-01 Impact factor: 6.918